Comparative analysis of skin sensitization potency of acrylates (methyl acrylate, ethyl acrylate, butyl acrylate, and ethylhexyl acrylate) using the local lymph node assay. 2007

Rebecca J Dearman, and Catherine J Betts, and Craig Farr, and James McLaughlin, and Nancy Berdasco, and Karin Wiench, and Ian Kimber
Immunology, Syngenta Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, SK1 4TJ, UK.

There are currently available no systematic experimental data on the skin sensitizing properties of acrylates that are of relevance in occupational settings. Limited information from previous guinea-pig tests or from the local lymph node assay (LLNA) is available; however, these data are incomplete and somewhat contradictory. For those reasons, we have examined in the LLNA 4 acrylates: butyl acrylate (BA), ethyl acrylate (EA), methyl acrylate (MA), and ethylhexyl acrylate (EHA). The LLNA data indicated that all 4 compounds have some potential to cause skin sensitization. In addition, the relative potencies of these acrylates were measured by derivation from LLNA dose-response analyses of EC3 values (the effective concentration of chemical required to induce a threefold increase in proliferation of draining lymph node cells compared with control values). On the basis of 1 scheme for the categorization of skin sensitization potency, BA, EA, and MA were each classified as weak sensitizers. Using the same scheme, EHA was considered a moderate sensitizer. However, it must be emphasized that the EC3 value for this chemical of 9.7% is on the borderline between moderate (<10%) and weak (>10%) categories. Thus, the judicious view is that all 4 chemicals possess relatively weak skin sensitizing potential.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000179 Acrylates Derivatives of acrylic acid (the structural formula CH2
D000485 Allergens Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). Allergen
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin
D017449 Dermatitis, Allergic Contact A contact dermatitis due to allergic sensitization to various substances. These substances subsequently produce inflammatory reactions in the skin of those who have acquired hypersensitivity to them as a result of prior exposure. Allergic Contact Dermatitis,Dermatitis, Allergic Eczematous,Dermatitis, Contact, Allergic,Allergic Contact Dermatitides,Allergic Eczematous Dermatitides,Allergic Eczematous Dermatitis,Contact Dermatitides, Allergic,Contact Dermatitis, Allergic,Dermatitides, Allergic Contact,Dermatitides, Allergic Eczematous,Eczematous Dermatitides, Allergic,Eczematous Dermatitis, Allergic
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Rebecca J Dearman, and Catherine J Betts, and Craig Farr, and James McLaughlin, and Nancy Berdasco, and Karin Wiench, and Ian Kimber
January 2010, Methods in molecular biology (Clifton, N.J.),
Rebecca J Dearman, and Catherine J Betts, and Craig Farr, and James McLaughlin, and Nancy Berdasco, and Karin Wiench, and Ian Kimber
December 2006, Journal of biomedical materials research. Part A,
Rebecca J Dearman, and Catherine J Betts, and Craig Farr, and James McLaughlin, and Nancy Berdasco, and Karin Wiench, and Ian Kimber
February 1997, Contact dermatitis,
Rebecca J Dearman, and Catherine J Betts, and Craig Farr, and James McLaughlin, and Nancy Berdasco, and Karin Wiench, and Ian Kimber
December 1995, Toxicology,
Rebecca J Dearman, and Catherine J Betts, and Craig Farr, and James McLaughlin, and Nancy Berdasco, and Karin Wiench, and Ian Kimber
June 2001, Trends in pharmacological sciences,
Rebecca J Dearman, and Catherine J Betts, and Craig Farr, and James McLaughlin, and Nancy Berdasco, and Karin Wiench, and Ian Kimber
January 2004, Journal of applied toxicology : JAT,
Rebecca J Dearman, and Catherine J Betts, and Craig Farr, and James McLaughlin, and Nancy Berdasco, and Karin Wiench, and Ian Kimber
August 2001, Contact dermatitis,
Rebecca J Dearman, and Catherine J Betts, and Craig Farr, and James McLaughlin, and Nancy Berdasco, and Karin Wiench, and Ian Kimber
December 1999, Contact dermatitis,
Rebecca J Dearman, and Catherine J Betts, and Craig Farr, and James McLaughlin, and Nancy Berdasco, and Karin Wiench, and Ian Kimber
June 2004, Regulatory toxicology and pharmacology : RTP,
Rebecca J Dearman, and Catherine J Betts, and Craig Farr, and James McLaughlin, and Nancy Berdasco, and Karin Wiench, and Ian Kimber
April 2007, Contact dermatitis,
Copied contents to your clipboard!